Where can I learn more about this study?
You can find more information about this study on the websites listed below.
X www.clinicaltrials.gov Once you are on the website, type “NCT03654313”
into the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com Once you are on the website, type “D4920C00001”
into the search box, and click “Find a Study”.
Full Study Title: A Phase 1 Randomized, Blinded, Placebo-controlled Study to Evaluate the
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of MEDI6570 in Subjects
With Type 2 Diabetes Mellitus
MedImmune LLC Protocol Number: D4920C00001
National Clinical Trials Number: NCT03654313
MedImmune LLC sponsored this study and has its headquarters at Gaithersburg, MD, USA.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and find
medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_07_21
12 | Clinical Study Results